Compare Riken Vitamin Co., Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 13.31%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 48.02
3
Poor long term growth as Net Sales has grown by an annual rate of 3.81% over the last 5 years
4
Flat results in Dec 25
5
With ROE of 11.50%, it has a very attractive valuation with a 1.09 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.79%
0%
-15.79%
6 Months
-5.36%
0%
-5.36%
1 Year
4.29%
0%
4.29%
2 Years
4.61%
0%
4.61%
3 Years
31.59%
0%
31.59%
4 Years
59.23%
0%
59.23%
5 Years
93.62%
0%
93.62%
Riken Vitamin Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.81%
EBIT Growth (5y)
53.51%
EBIT to Interest (avg)
48.02
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
1.03
Tax Ratio
26.08%
Dividend Payout Ratio
30.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.75%
ROE (avg)
13.31%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.09
EV to EBIT
11.62
EV to EBITDA
7.01
EV to Capital Employed
1.11
EV to Sales
0.84
PEG Ratio
0.90
Dividend Yield
NA
ROCE (Latest)
9.52%
ROE (Latest)
11.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
25,238.00
25,703.00
-1.81%
Operating Profit (PBDIT) excl Other Income
3,659.00
3,728.00
-1.85%
Interest
27.00
30.00
-10.00%
Exceptional Items
144.00
-41.00
451.22%
Consolidate Net Profit
2,587.00
2,579.00
0.31%
Operating Profit Margin (Excl OI)
64.30%
113.60%
-4.93%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -1.81% vs 5.15% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 0.31% vs 6.84% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
95,582.00
91,484.00
4.48%
Operating Profit (PBDIT) excl Other Income
11,929.00
12,702.00
-6.09%
Interest
123.00
112.00
9.82%
Exceptional Items
-847.00
-216.00
-292.13%
Consolidate Net Profit
9,392.00
8,759.00
7.23%
Operating Profit Margin (Excl OI)
91.30%
102.40%
-1.11%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 4.48% vs 3.08% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 7.23% vs 36.50% in Mar 2024
About Riken Vitamin Co., Ltd. 
Riken Vitamin Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






